Abstract

Objective: Cytomegalovirus (CMV) pneumonia in immunocompetent children remains underrecognized, and standardized diagnostic criteria are lacking. We aimed to describe the clinical characteristics of immunocompetent children with CMV pneumonia and to evaluate the relationship between bronchoalveolar lavage (BAL) fluid and serum CMV DNA loads and laboratory results.

Materials and Methods: In this retrospective cohort study, medical records of 62 immunocompetent children who underwent flexible bronchoscopy for recurrent pneumonia or persistent wheezing between November 2023 and January 2025 were reviewed. CMV pneumonia was defined by detection of CMV DNA in BAL using real-time polymerase chain reaction (PCR). Quantitative CMV DNA load in BAL and serum were expressed as international units per milliliter (IU/mL). Demographic, clinical, laboratory, and radiological findings were recorded. Correlations between CMV DNA load in BAL and serum and blood indices were analyzed.

Results: Twenty patients (32.2%) were diagnosed with CMV pneumonia. The median age was six years (1.5-9.7), and 55% were male. The most common presenting symptom was chronic cough (85%). Patchy consolidation was the most frequent radiographic finding (45%), while chest computed tomography most commonly demonstrated consolidation (55%), often with bilateral (70%) and multilobar involvement (70%). Serum CMV PCR was positive in six patients (30%). No significant correlation was observed between BAL CMV DNA load (median; 2650 IU/mL; IQR; 311-16874) and serum CMV DNA load (median; 700 IU/mL; IQR; 443-2650) (p > 0.963). BAL CMV DNA load showed a strong positive correlation with serum monocyte count (r = 0.861, p<0.001) and mean platelet volume (MPV) (r = 0.759, p < 0.001). Eleven patients (55%) received intravenous ganciclovir at 5 mg/kg/per dose twice daily for 21 days, and demonstrated clinical and radiological improvement without documented significant adverse effects.

Conclusion: BAL CMV PCR demonstrated a higher detection rate than serum CMV PCR in immunocompetent children with recurrent pneumonia or persistent wheezing. Elevated monocyte count and MPV may reflect CMV-related pulmonary inflammation.

Keywords: Bronchoscopy, bronchoalveolar lavage, children, cytomegalovirus, pneumonia

References

  1. Britt WJ. Cytomegalovirus. In: Kliegman RM, St Geme III JW, Blum NJ, Tasker RC, Shah SS, Wilson KM (eds). Nelson Textbook of Pediatrics (20th ed) Vol 1. Philadelphia: Elsevier, 2016: 1590-3.
  2. Brito F, Brune L, Stahl W. Cytomegalovirus (CMV) Pneumonitis: Cell Tropism, Inflammation, and Immunity. Int J Mol Sci. 2019;20(16):3865. https://doi.org/10.3390/ijms20163865
  3. Vora SB, Englund JA. Cytomegalovirus in immunocompromised children. Curr Opin Infect Dis. 2015;28(4): 323–9. https://doi.org/10.1097/QCO.0000000000000174
  4. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47. https://doi.org/10.1186/1743-422X-5-47
  5. Cinel G, Pekcan S, Ozçelik U, et al. Cytomegalovirus infection in immunocompetent wheezy infants: the diagnostic value of CMV PCR in bronchoalveolar lavage fluid. J Clin Pharm Ther. 2014;39: 399–403. https://doi.org/10.1111/jcpt.12169
  6. Sun H, Li S, Yan Y, et al. Associations between patient clinical characteristics and the presence of cytomegalovirus DNA in the bronchoalveolar lavage fluid of children with recurrent wheezing. BMC Infect Dis. 2018;18: 458. https://doi.org/10.1186/s12879-018-3345-9
  7. Öztürk GK. Cytomegalovirus Lung Infections. in: Gülen F, editor. Çocukluk Çağı Solunum Yolu Enfeksiyonları. Ankara: Türkiye Klinikleri; 2021. p.87-93.
  8. Pokorska-Śpiewak M, Niezgoda A, Gołkowska M, et al. Recommendations for the diagnosis and treatment of CMV infections. Polish Society of Epidemiology and Infectious Diseases. Przegl Epidemiol. 2016;70: 297–310.
  9. Jiang W, Chen S, Xu L, et al. Presence of Cytomegalovirus infection is associated with an unfavorable outcome in immunocompetent infants with pertussis. Front Cell Infect Microbiol. 2022;12: 800452. https://doi.org/10.3389/fcimb.2022.800452
  10. Özsürekci Y, Öncel EK, Ceyhan M. Diagnostic approaches and problems of infections caused by cytomegalovirus. Çocuk Sağlığı ve Hastalıkları Dergisi 2016; 59: 182-7. Available from: https://cshd.org.tr/article/view/98
  11. Alfaro W, Avila- Agiiero CR. Ganciclovir therapy in cytomegalovirus (CmV) infection in im-munocompetent pediatric patients. ınt j ınfect Dis. 2003;7: 278–81. https://doi.org/10.1016/s1201-9712(03)90107-x
  12. Lin X, Wan Y, Liu Y. Efficacy of ganciclovir in the treatment of cytomegalovirus (CMV) infection in infants and its effect on inflammatory reaction and immune function. Am J Transl Res. 2023;15: 6514–6523.
  13. Centers for Disease Control and Prevention (CDC) Growth calculator for 2 to 20 years. (cited 8 Feb 2026). Available at: https:// peditools.org/growthpedi/index.php
  14. Faro A, Wood RE, Schechter MS, et al. Official American Thoracic Society technical standards: flexible airway endoscopy in children. Am J Respir Crit Care Med. 2015; 191: 1066–80. https://doi.org/10.1164/rccm.201503-0474ST.
  15. de Blic J, Midulla F, Barbato A, et al. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J. 2000;15(1):217-31. https://doi.org/10.1183/09031936.00.15121700
  16. Crooks BN, Taylor CE, Turner AJ, et al. Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit. Bone Marrow Transplant. 2000;26: 1097–102.
  17. Wu J-L, Ma H-Y, Lu C-Y, et al. Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients. J Microbiol Immunol Infect. 2017;50: 307–13. https://doi.org/10.1016/j.jmii.2015.07.011
  18. Lau CE, DiTullio DJ, Wilhalme H, Bowles L, Moore TB, De Oliveira SN. Prevalence of viral infections and serious complications in pediatric hematopoietic stem cell transplant patients: A ten-year single-institution retrospective study. J Hematol (Brossard). 2025;14:1–13. https://doi.org/10.14740/jh1376
  19. Restrepo-Gualteros SM, Gutierrez MJ, Villamil-Osorio M, Arroyo MA, Nino G. Challenges and clinical implications of the diagnosis of Cytomegalovirus lung infection in children. Curr Infect Dis Rep. 2019;21(7):24. https://doi.org/10.1007/s11908-019-0681-x
  20. Govender K, Jeena P, Parboosing R. Clinical utility of bronchoalveolar lavage cytomegalovirus viral loads in the diagnosis of cytomegalovirus pneumonitis in infants: Utility of BAL CMV Viral Load in Infant CMV Pneumonitis. J Med Virol. 2017;89(6): 1080–7. https://doi.org/10.1002/jmv.24730
  21. Saksirisampant G, Kawamatawong T, Promsombat K, et al. A prospective study of plasma and bronchoalveolar lavage fluid CMV DNA load quantification for the diagnosis and outcome of CMV pneumonitis in immunocompromised hosts. J Clin Virol. 2022;155: 105243. https://doi.org/10.1016/j.jcv.2022.105243
  22. Boeckh M, Stevens-Ayers T, Travi G, et al. Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia. J Infect Dis. 2017;215(10):1514-22. https://doi.org/10.1093/infdis/jix048.
  23. Lodding IP, Schultz HH, Jensen JU, Kirkby N, Perch M, Andersen C, Lundgren JD, Iversen M. Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia. Transplantation. 2018;102(2):326-32. https://doi.org/10.1097/TP.0000000000001927.
  24. Berengua C, Miró E, Gutiérrez C, et al. Detection of cytomegalovirus in bronchoalveolar lavage fluid from immunocompromised patients with pneumonitis by viral culture and DNA quantification. J Virol Methods. 2023;317:114743. https://doi.org/10.1016/j.jviromet.2023.114743
  25. Patel AA, Zhang Y, Fullerton JN, et al. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J Exp Med. 2017;214: 1913–23. https://doi.org/10.1084/jem.20170355
  26. Min C-K, Shakya AK, Lee B-J, Streblow DN, Caposio P, Yurochko AD. The differentiation of human Cytomegalovirus infected-monocytes is required for viral replication. Front Cell Infect Microbiol. 2020;10: 368. https://doi.org/10.3389/fcimb.2020.00368
  27. Zdziarski P, Gamian A. High monocyte count associated with human Cytomegalovirus replication in vivo and glucocorticoid therapy may be a hallmark of disease. Int J Mol Sci. 2022;23: 9595. https://doi.org/10.3390/ijms23179595
  28. Smith MS, Bentz GL, Alexander JS, Yurochko AD. Human Cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J Virol. 2004;78: 4444–53. https://doi.org/10.1128/jvi.78.9.4444-4453.2004
  29. Beceren NG, Armağan HH, Oğuzlar FÇ, Cesur E, Gürdal O, Tomruk Ö. Can mean platelet volume be a prognosis predictor in viral infections: An example of Covid-19. Heliyon. 2023;9: e21983. https://doi.org/10.1016/j.heliyon.2023.e21983
  30. Gunluoglu G, Yazar EE, Veske NS, Seyhan EC, Altin S. Mean platelet volume as an inflammation marker in active pulmonary tuberculosis. Multidiscip Respir Med. 2014;9: 11.
  31. Gumus H, Demir A, Yükkaldıran A. Is mean platelet volume a predictive marker for the diagnosis of COVID-19 in children? Int J Clin Pract. 2021;75. https://doi.org/10.1186/2049-6958-9-11
  32. Doan TTM, Phung TTB, Pham HV, Pham SH, Nguyen LT. Effect of ganciclovir for the treatment of severe cytomegalovirus-associated pneumonia in children without a specific immunocompromised state. BMC Infect Dis. 2013;13: 424. https://doi.org/10.1186/1471-2334-13-424
  33. Luck SE, Wieringa JW, Blázquez-Gamero D, et al. Congenital Cytomegalovirus: A European expert consensus statement on diagnosis and management. Pediatr Infect Dis J. 2017;36: 1205–13. https://doi.org/10.1097/INF.0000000000001763

How to cite

1.
Ocak E, Sarıtaş ÜA, Akay Hacı İ, Mert Doğan G, Yılmaz D. Sitomegalovirüs pnömonisi olan bağışıklık sistemi normal olan çocukların klinik özellikleri: Tek merkezli retrospektif kohort çalışması. Turk J Pediatr Dis. 2026;Early View:1-8. https://doi.org/10.12956/TJPD.2025.1297